Skip to content
PICO Portalanswers from OpenAlex

Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area

PaperCitations, authors & open-access status

Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area is a paper indexed in PICO Portal from OpenAlex.

How many citations does Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area have?

PICO Portalcitation count

Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area has 59 citations in the OpenAlex counts PICO Portal stores.

When was Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area published?

PICO Portalyear

Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area has 2013 year in the PICO Portal index.

What is the open-access status of Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area?

PICO Portaloa status

Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area has bronze oa status in the PICO Portal index.

What is the DOI of Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area?

PICO Portaldoi

The DOI for Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area is on the source record.

What is the PMID of Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area?

PICO Portalpmid

The PMID for Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area is on the source record.

What is the OpenAlex record for Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area?

PICO Portalopenalex

The OpenAlex for Clinical Evaluation of a Ten‐Day Regimen with <scp>E</scp>someprazole, <scp>M</scp>etronidazole, <scp>A</scp>moxicillin, and <scp>C</scp>larithromycin for the Eradication of <i><scp>H</scp>elicobacter pylori</i> in a High Clarithromycin Resistance Area is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial